Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges : Protocol for a pragmatic randomised controlled trial by Henderson, Joanna L. et al.
This is a repository copy of Integrated collaborative care teams to enhance service 
delivery to youth with mental health and substance use challenges : Protocol for a 
pragmatic randomised controlled trial.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/154792/
Article:
Henderson, Joanna L., Cheung, Amy, Cleverley, Kristin et al. (12 more authors) (2017) 
Integrated collaborative care teams to enhance service delivery to youth with mental 
health and substance use challenges : Protocol for a pragmatic randomised controlled 
trial. BMJ Open. e014080. ISSN 2044-6055 
https://doi.org/10.1136/bmjopen-2016-014080
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial (CC BY-NC) 
licence. This licence allows you to remix, tweak, and build upon this work non-commercially, and any new 
works must also acknowledge the authors and be non-commercial. You don’t have to license any derivative 
works on the same terms. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Integrated collaborative care teams
to enhance service delivery to youth
with mental health and substance use
challenges: protocol for a pragmatic
randomised controlled trial
Joanna L Henderson,1 Amy Cheung,2 Kristin Cleverley,3 Gloria Chaim,1
Myla E Moretti,4 Claire de Oliveira,1 Lisa D Hawke,1 Andrew R Willan,5
David O’Brien,6 Olivia Heffernan,1 Tyson Herzog,1 Lynn Courey,7
Heather McDonald,8 Enid Grant,9 Peter Szatmari1
To cite: Henderson JL,
Cheung A, Cleverley K, et al.
Integrated collaborative care
teams to enhance service
delivery to youth with mental
health and substance use
challenges: protocol for a
pragmatic randomised
controlled trial. BMJ Open
2017;7:e014080.
doi:10.1136/bmjopen-2016-
014080
▸ Prepublication history and
additional material is
available. To view please visit
the journal (http://dx.doi.org/
10.1136/bmjopen-2016-
014080).
Received 30 August 2016
Revised 29 November 2016
Accepted 5 January 2017
For numbered affiliations see
end of article.
Correspondence to
Dr Joanna L Henderson;
joanna.henderson@camh.ca
ABSTRACT
Introduction: Among youth, the prevalence of mental
health and addiction (MHA) disorders is roughly 20%,
yet youth are challenged to access evidence-based
services in a timely fashion. To address MHA system
gaps, this study tests the benefits of an Integrated
Collaborative Care Team (ICCT) model for youth with
MHA challenges. A rapid, stepped-care approach
geared to need in a youth-friendly environment is
expected to result in better youth MHA outcomes.
Moreover, the ICCT approach is expected to decrease
service wait-times, be more youth-friendly and family-
friendly, and be more cost-effective, providing
substantial public health benefits.
Methods and analysis: In partnership with four
community agencies, four adolescent psychiatry
hospital departments, youth and family members with
lived experience of MHA service use, and other
stakeholders, we have developed an innovative model
of collaborative, community-based service provision
involving rapid access to needs-based MHA services.
A total of 500 youth presenting for hospital-based,
outpatient psychiatric service will be randomised to
ICCT services or hospital-based treatment as usual,
following a pragmatic randomised controlled trial
design. The primary outcome variable will be the
youth’s functioning, assessed at intake, 6 months and
12 months. Secondary outcomes will include clinical
change, youth/family satisfaction and perception of
care, empowerment, engagement and the incremental
cost-effectiveness ratio (ICER). Intent-to-treat analyses
will be used on repeated-measures data, along with
cost-effectiveness and cost-utility analyses, to
determine intervention effectiveness.
Ethics and dissemination: Research Ethics Board
approval has been received from the Centre for
Addiction and Mental Health, as well as institutional
ethical approval from participating community sites.
This study will be conducted according to Good
Clinical Practice guidelines. Participants will provide
informed consent prior to study participation and data
confidentiality will be ensured. A data safety
monitoring panel will monitor the study. Results will
be disseminated through community and peer-reviewed
academic channels.
Trial registration number: Clinicaltrials.gov
NCT02836080.
BACKGROUND
Research has shown that ∼20% of Canadian
adolescents are affected by mental health
and addiction (MHA) disorders.1 Most
mental disorders begin early in life and
persist, either as the same or as a new dis-
order. It is estimated that 75% of all adult
mental disorders arise before the age of
16 years.2 Some 10% of individuals seeking
specialised addictions treatment in Ontario,
Canada are youth under the age of 18 years.3
The disease burden associated with MHA
Strengths and limitations of this study
▪ Pragmatic randomised controlled trial design to
test the benefits of the integrated collaborative
care team model involving multiple community
and academic collaborators.
▪ Inclusion of economic evaluation, patient-
oriented outcomes and minimal exclusion
criteria.
▪ Involvement of youth, family members and other
stakeholders through all stages of project design.
▪ Inability to identify the differential impact of the
systems of care or specific service components
for individuals with specific mental health/addic-
tion challenges.
▪ Inability to assess long-term impact past 1 year.
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disorders is more than 1.5 times that of all cancers and
more than seven times that of all infectious diseases.4
Adolescence is an optimal time to intervene for MHA
challenges, to reduce both individual suffering and long-
term population burden.5 6
Two recent landmark publications on primary mental
healthcare for youth concluded that service reach is sub-
stantially limited by multiple access barriers and by a
dearth of evidence-based services designed for this
developmental stage.2 7 Many models of service delivery
fail to consider the particular contexts in which youth
ﬁnd themselves, for example, schools, youth protection
settings, the youth justice system, homeless shelters and
colleges or universities. Models also fail to consider the
lack of engagement that youth feel with a ‘children’s’
mental health agency or an ‘adult’ psychiatric service.
Further, waiting lists for youth mental health services are
unacceptably long in many jurisdictions.8 9 Exacerbating
this series of problems, many services impose arbitrary
limitations on access, such as excluding youth with mul-
tiple diagnoses. The perspectives of youth and family
members are rarely integrated in service planning, devel-
opment and research, thereby missing out on the bene-
ﬁts that have been shown to be provided through
patient-oriented research and care.10
Currently, Canadian youth have great difﬁculty acces-
sing effective evidence-based mental healthcare that is
timely and user-friendly. In Ontario, youth and their
families have characterised the adolescent mental health
system as fragmented, under-resourced, unresponsive,
and inefﬁcient.11 Only 25-30% of youth with MHA chal-
lenges access specialised treatment, and most do not
receive evidence-based treatment in a timely manner,
resulting in functional impairment, poor quality of life
and negative impacts on attaining important develop-
mental milestones.1 4
Taken together, these problems create a crisis of
access and engagement for youth needing developmen-
tally sensitive, youth-oriented mental health services.12
This crisis is not due to a lack of research evidence. On
the contrary, the previous decade has seen a plethora of
new studies on effective mental health interventions for
youth, with accompanying clinical practice guidelines
and consensus statements.13 The critical problem lies
with inadequate implementation of evidence-based
interventions across multiple real world settings and jur-
isdictions.13 The youth mental health system urgently
needs transformative change that simultaneously
addresses all system levels and meaningfully integrates
youth and family members.
We propose to address the service gap for youth with
MHA challenges within Ontario’s current MHA system
by developing and implementing an Integrated
Collaborative Care Team (ICCT) model. This new
model for Ontario consists of several linked,
evidence-informed components, including solution-
focused brief therapy (SFBT)14–16 on a scheduled and
walk-in basis; access to primary care; care navigators;
dialectical behavioural therapy (DBT) skills groups for
youth,17 family-focused interventions18; e-health support
tools; and peer mentorship/support,19 all colocated in
youth-friendly, community-based walk-in clinics. In add-
ition to these services, some youth with more severe pro-
blems may need to be fast-tracked to immediate medical
and specialised mental health services, including psychi-
atric consultation and medication management. The
main ingredients of the model (a ‘stepped care’ process,
short wait times, multiple standardised evidence-informed
interventions in a single setting) are hypothesised to
provide better outcomes compared to the usual treatment
typically provided in local hospital outpatient clinics.
Each of these components is an evidence-informed
intervention identiﬁed as holding promise for the
healthcare system. SFBT is an evidence-informed treat-
ment approach that has demonstrated efﬁcacy for youth
internalising and externalising symptoms in only a few
sessions, especially as an early, low-intensity interven-
tion.15 20 The SFBT approach is strengths-based and
guides the individual toward concrete solutions to the
issues at hand. The evidence for SFBT suggests that it
may be cost-effective and feasible for use in community
mental health sites. DBT is a treatment that has been
demonstrated effective in reducing self-harm and
chronic suicidality, notably among individuals with bor-
derline personality disorder.21 Core foci of the interven-
tion include decreasing emotional dysregulation,
teaching mindfulness skills, enhancing distress tolerance
and improving interpersonal effectiveness. Based on the
success of the model, DBT has been modiﬁed and
expanded for use as an effective transdiagnostic treat-
ment for youth with other MHA concerns, with a focus
on emotional dysregulation.17 Family-focused applica-
tions of DBT have also demonstrated substantial bene-
ﬁts.18 Peer support, which was identiﬁed as a priority in
our recent review of youth mental health services in
Ontario,22 has been shown to increase a sense of hope,
empowerment and social functioning, while reducing
stigma and possibly even hospitalisation.19 Collaborative
mental healthcare spaces that bring these and other
services together have been shown to produce strong
outcomes for presenting youth.23 24 By combining low,
moderate and high-intensity services in a youth-friendly
space, this new stepped-care ICCT model may provide a
timely, well-rounded response to youth with MHA
challenges.
STUDY OBJECTIVES
The current study will evaluate the intervention effect-
iveness and cost-effectiveness of the above-described
multicomponent ICCT model compared to hospital-
based outpatient treatment as usual (TAU) for youth
with mental health and/or addictions challenges using a
pragmatic randomised controlled trial (RCT) design. In
addition, it will document the process of cocreating and
implementing the ICCT model.
2 Henderson JL, et al. BMJ Open 2017;7:e014080. doi:10.1136/bmjopen-2016-014080
Open Access
Protected by copyright.
 o
n
 D
ecem
ber 18, 2019 at The Librarian J B M
orrell Library.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-014080 on 6 February 2017. Downloaded from 
Primary objective
1. Following a patient-oriented research model, to work
together with youth, family members and stake-
holders to test the beneﬁts of an ICCT model in
improving functioning among youth aged 14–
18 years with MHA challenges, compared to TAU
Secondary objectives
2. To assess clinical improvement under the ICCT com-
pared to TAU
3. To determine whether youth and participating family
members experience greater satisfaction, engage-
ment and empowerment with the treatments pro-
vided under the ICCT model compared to TAU
4. To determine the cost-effectiveness of the ICCT
model compared to TAU
5. To document the co-creation and implementation of
the ICCT model by youth, family members, commu-
nity and hospital service providers, researchers and
other stakeholders
METHODS
Study design
This study implements a pragmatic RCT design with
random allocation of youth aged 14–18 years to either
TAU at one of four outpatient hospital sites or ICCT
treatment at one of three community-based sites, all in
Toronto, Canada. The hospitals include the Centre for
Addiction and Mental Health (CAMH), the Hospital for
Sick Children (SickKids), Sunnybrook Health Sciences
Centre and Michael Garron Hospital (MGH). The ICCT
services will be provided by East Metro Youth Services
(EMYS), Skylark Children, Youth and Families, LOFT
Community Services and Sashbear Foundation, in col-
laboration with the South East Toronto Family Health
Team, and the Anne Johnston Health Station.
Project management and participation plan
The project is governed by multistakeholder groups,
including representatives of the four hospital sites, com-
munity agencies, youth and family members. The Core
Team is composed of the principal investigators and
research team members, as well as site representatives
and youth and family member coinvestigators. This team
is supported by four working groups focusing on (1)
community services, (2) study methodology, (3) hospital
processes and (4) implementation science. Participating
in each working group are also two youth advisors to
provide the youth voice to the project. Youth and family
advisory groups have also been established to facilitate
patient-oriented research. The full project team includes
collaborators from various research, clinical and broader
community specialties ensuring that the necessary
expertise is available for all aspects of the project. This
represents an academic-stakeholder cocreation model
that can maximise relevance and impact of the study
and intervention design.25
Participant selection and withdrawal
Participant recruitment: Participant recruitment will be
conducted at the four Toronto hospital sites.
Recruitment will take place over a 12-month period. A
total of 500 youth will be randomised into the study; 250
will be randomised to ICCT and 250 to TAU. For each
youth, the participation of one family member (ie, a
primary caregiver) in the study process will be encour-
aged, but is optional. Across hospitals, the following pro-
cedures will be used as appropriate and feasible:
hospital intake staff will identify new referrals for appro-
priateness for referral to the project; standardised tele-
phone screening calls will be conducted by clinical
research assistants (RAs); a visit will then be scheduled
at a neutral community site with the youth and family
member (if any) for consent, enrolment, intake assess-
ments and randomisation. Those who do not meet the
criteria or who do not agree to participate in the study
will be immediately connected with a regular hospital
appointment outside of the research study. For partici-
pants who are randomised to the ICCT arm, Consent for
Disclosure of Personal Health Information will be com-
pleted to enable the clinical RA to forward referral
information to the ICCT, as well as a standardised letter
indicating referral to the ICCT to the referring phys-
ician, to ensure adequate information sharing.
Participating youth will receive honoraria in the form of
gift cards valued at $50 at time 1, time 2 and time
3. Caregivers will receive $25 in gift cards at each time
point, as well as entry into a random draw for a $250 gift
card. The study is currently in the recruitment phase;
the ﬁrst participant was enrolled on 19 September 2016.
Inclusion and exclusion criteria. To be eligible, youth
must be between 14 and 18 years of age at the time of
presentation (the common age range of services at the
four hospital sites), referred to one of the four partici-
pating hospitals with MHA challenges and be among
the population regularly accepted for outpatient adoles-
cent psychiatric services at that hospital. An individual
meeting any of the following criteria will be excluded
from participation in the study: referral for specialty
forensic or ﬁresetting treatment; autism without MHA
problems; primary diagnosis of an eating disorder; active
psychosis or imminent risk of self-harm requiring imme-
diate intervention; inability to read and write in English
due to the self-report assessment component; and inabil-
ity to consent to the study. As a pragmatic trial, exclusion
criteria are intentionally minimised to ensure an inclu-
sive sample representative of the youth who would nor-
mally be targeted by this service delivery model. Family
member participants must be a primary caregiver of the
youth and aware of the youth’s everyday functioning.
Exclusion criteria are the inability to read and write in
English or to consent to the study.
Consent and withdrawal from study: Informed, signed
consent will be obtained from all study participants at
the intake visit prior to study enrolment and randomisa-
tion (see online supplementary appendix A and B). If
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youth/family members wish more time to consider par-
ticipation, a second intake visit will be scheduled. Youth
will provide consent rather than assent regardless of age,
as they are considered to play an equal role in the deci-
sion to participate in research. The family member will
consent for his/her own respective participation. Copies
of the signed consent forms will be given to the youth
and family member; originals will be ﬁled securely in
study ﬁles. Participation will be voluntary and partici-
pants will be free to withdraw from the study at any time
without affecting their treatment. Whether assigned to
the TAU or ICCT arm, youth will be able to continue
receiving full treatment within that model if they with-
draw from the study. If youth randomised to the ICCT
arm withdraw from the study and wish to receive treat-
ment as usual in the hospital setting, the research team
will assist them in returning to the original hospital to
schedule treatment. Other youth who withdraw from the
research project and request community services will be
provided with information about available services.
Study interventions
Integrated collaborative care teams: ICCT treatments and ser-
vices are summarised in table 1. ICCTs are housed in
the community in three neighbourhoods across
Toronto, Canada. Each ICCT will include MHA care pro-
viders (eg, youth worker, social worker, psychiatrist,
nurse practitioner), trained peer support workers, access
to a primary care providers and a care navigator
responsible for working with the various specialists to
coordinate care. For each intervention, standardised
intervention protocols will be used, employing evidence-
informed sources wherever possible. All participants will
begin with rapid access to a SFBT session14 15 as a
gateway to the ICCT services; this will serve as a brief
intervention, as well as to identify the needs and prefer-
ences of the youth and his or her family member and to
develop a treatment plan. Subsequent interventions will
then be selected based on need, using clinical assess-
ments and selected by the ICCT service provider in a
stepped-care manner.
Youth will be offered higher or lower intensity services,
following a needs-based staging model.26 The Columbia
Suicide Scale Clinical Practice Screener27 and PRIME
Screen28 prodrome screener will be used clinically with
all youth across ICCT sites to identify risk suggesting the
need for high-intensity/high-risk psychiatric services in
the presence of psychotic prodromal or suicidal symp-
toms. The HEADS-ED29 will be used clinically by ICCT
service providers to identify the functional level of the
youth, suggesting moderate intensity when both risk and
functioning are low, but low intensity when risk is low
and functioning is high. These scales will be followed to
inform treatment planning based on a treatment algo-
rithm provided to the community sites, in conjunction
with the service provider’s judgement of treatment
response and youth/family preference or expressed
need.
The low-intensity intervention will consist of SFBT, a
goal-directed single-session intervention that focuses on
the youth’s strengths and identiﬁes concrete solutions;
this will be provided by the ICCT service provider. Youth
will receive an established number of single-session
SFBT sessions based on need and will have ongoing
access to the SFBT model through the ICCT walk-in ser-
vices. The moderate-intensity intervention will be a
modular DBT skills group, provided by group facilitators
at each site and consisting of modules focusing on deve-
loping the emotional regulation, distress tolerance and
interpersonal effectiveness skills of the youth. The high-
intensity psychiatric response will consist of management
by a child and adolescent psychiatrist within the ICCT
environment, and/or a Nurse Practitioner, focusing on
psychiatric assessment, medication management and
Table 1 Summary of ICCT study interventions and the
treatment selection pathway
Intake (all youth) Randomisation to ICCT intake:
▸ Solution-Focused Brief Therapy
Session14–16
▸ Assessment and treatment
planning
▸ Care Navigator
▸ Assertive Outreach (as needed)
Low-intensity
interventions
Intake interventions, plus:
▸ Continued Solution-Focused Brief
Therapy14–16
▸ Family Connections DBT-based
group for family members18
▸ Primary Care (as needed)
▸ Assertive Outreach (as needed)
Moderate-intensity
interventions
Intake interventions, plus:
▸ DBT-based skills group17
▸ Family Connections DBT-based
group for family members18
▸ Primary Care (as needed)
▸ Assertive Outreach (as needed)
High-intensity
interventions
Intake interventions, plus:
▸ High-intensity psychiatric response
—Psychiatrist/Nurse Practitioner
▸ Family Connections DBT-based
group for family members18
▸ Primary Care (as needed)
▸ Assertive Outreach (as needed)
Additional options
within the ICCT
model
▸ Peer support mentor19
▸ Peer support drop-in group
▸ E-health support tools
▸ 24/7 crisis text support
Additional options
available through
participating
agencies
▸ Drop-in activity area
▸ Group/individual DBT
▸ Group/individual CBT
▸ Support groups (various)
▸ Family-specific interventions
▸ External agency service
▸ Other counselling
CBT, cognitive-behavioral therapy; DBT,dialectical behavioural
therapy; ICCT,Integrated Collaborative Care Team.
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other interventions deemed clinically appropriate; treat-
ment duration will be based on need, as assessed by the
clinician. Family members will be offered participation
in Family Connections, a DBT-based skills and support
group designed for families,17 regardless of the youth’s
risk and functional level. Additional community services
will be offered to youth/family members where appro-
priate. Since the study aims to evaluate the effectiveness
of the pathway rather than the speciﬁc effectiveness of
each individual intervention, intervention ﬁdelity will be
monitored at the level of delivery of intervention
modules, components and subcomponents; service pro-
viders will document the delivery of intervention
modules, components and subcomponents for each
youth and/or family member using detailed self-report
intervention logs and checklists.
Treatment as usual: The TAU condition consists of the
standard outpatient treatment provided at each partici-
pating hospital site. This typically entails assessment and
treatment planning by a psychiatrist at the participating
hospital, and may include medication, psychotherapy
and/or internal and external referrals to treatment and
other services, guided by local service standards. The
hospital services used in the TAU condition will be
tracked for each participant using chart review (based
on medical record numbers).
Application of interventions: Each hospital and ICCT site
will be responsible for the application of the appropriate
clinical interventions. Training in core ICCT interven-
tions (SFBT, DBT Skills Group, Family Connections) has
been conducted together in a single group, using the
same treatment manual. It is expected that interventions
will be selected for each youth based on the clinical
assessments and the related treatment algorithm pro-
vided to the clinical sites, complemented by the clinical
judgement of the site staff and drawing from the avail-
able services, taking into consideration youth and family
member preferences.
Outcome measures
Outcome measures are summarised in table 2. For psy-
chometric properties, see online supplementary
appendix C.
Sample description: To describe the basic characteristics
of the sample recruited into the study, a custom demo-
graphic information form will be administered to the
youth and family member. In addition, a clinical descrip-
tion of the sample will be provided by the Diagnostic
Interview for Affective and Anxiety Spectrum Disorders
—Child Version (DIAS-C)30, which is an interview that
will be administered by a trained clinical RA. Risk for
psychosis will be assessed by the self-report PRIME.28
Youth will also complete the PTSD CheckList—Civilian
Version (PCL-C)31 and a checklist indicating any
comorbid physical health conditions.
Clinical/functional outcome: The primary objective, to
test the beneﬁts of the ICCT model in improving func-
tioning among youth aged 14–18 years with MHA
challenges, will be measured using the Columbia
Impairment Scale (CIS)32. This self-report scale includes
13 items, versions for both youth and family members, is
reliable and valid, has been used in several clinical
trials33–35 and was chosen by youth in focus groups as
the main measure of interest to them. Youth CIS scores
will represent the primary outcome variable, with care-
giver CIS scores serving as a secondary outcome
variable.
Our second objective, to assess clinical improvement,
will be measured using the Strengths and Difﬁculties
Questionnaire (SDQ)36 in its versions for youth self-
report and parental report. Further symptom proﬁles,
including problematic substance use, will be assessed
using the GAIN Short Screener,37 which will be supple-
mented by the substance use table of the Adolescent
Alcohol and Drug Involvement Scale.38 An additional
clinical outcome will include caregiver burden, mea-
sured using the self-report Burden Assessment Scale
(BAS)39 administered to family members only.
Satisfaction, goal achievement, engagement, empowerment,
burden: Our third study objective, satisfaction with the
service models, will be assessed using the Ontario
Perception of Care Tool for Mental Health and
Addictions, client and family versions (OPOC)40. To
provide insight into goal achievement, each youth and
parent will be asked to determine his or her own goals
at intake; we will then use an 11-point progress scale
based on the Goal Progress Chart41 at the 6-month and
12-month assessments to determine the average extent
to which these goals were met. Further information on
client empowerment and engagement will be collected
using the self-report Family Empowerment Scale42 for
family members, the Youth Efﬁcacy/Empowerment
Scale43 for youth and the Continuity of Care in
Children’s Mental Health questionnaire44 in its family
member and youth versions.
Economic evaluation: Our ﬁnal objective is to determine
the cost-effectiveness of the ICCT model compared to
TAU. We will perform two analyses, a cost-effectiveness
analysis (CEA) and a cost-utility analysis (CUA), to deter-
mine the incremental costs of ICCT compared to TAU
in modifying health outcomes as measured by the CIS
and quality-adjusted life years (QALYs) measured with a
validated utility instrument, the Assessment of Quality of
Life-6D (AQOL-6D)45. The AQOL-6D will be adminis-
tered at baseline and at 6 and 12 months to determine
the change in utility for the duration of the interven-
tion, and will be used to calculate QALYs. Custom data
collection tools have been developed to measure direct
costs to the youth/family member, as well as indirect
costs (eg, lost income due to appointments; see table 3
for a detailed description of each cost category). These
tools will be completed by treatment teams in the
respective treatment arms and by the youth and their
family member (if applicable). This data will be col-
lected at all three assessment times. Additional data
regarding health services use and direct costs to the
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Table 2 Summary of research assessment tools selected for the study
Objective Instrument Reporter Key construct Subscales
Measurement
time(s)
Sample
description
Custom questionnaire Youth, Family
member
Demographic
characteristics
None Intake
DIAS-C30 Clinical
Research
Assistant
Clinical
Improvement
Mood disorders, anxiety
disorders, externalising
disorders
Intake
Custom checklist Youth, Family
member
Physical health
variables
None Intake
PRIME28 Youth Prodrome for
psychosis
None Intake
PCL-C31 Youth PTSD
symptoms
None Intake
Functional
improvement
Columbia Impairment
Scale32
Youth, Family
member
Impairment None Intake, 6 months,
12 months
Clinical
improvement
Strengths and
Difficulties
Questionnaire36
Youth, Family
member
Clinical
Improvement
Emotional problems,
conduct problems,
hyperactivity, peer
problems, prosocial
Intake, 6 months,
12 months
GAIN SS37 Youth Clinical
symptoms
Internalising disorders,
externalising disorders,
substance use disorders,
crime/violence
Intake, 6 months,
12 months
Adolescent Alcohol and
Drug Involvement
Scale38
Youth Problematic
substance use
None Intake, 6 months,
12 months
Burden Assessment
Scale39
Family
member
Family Burden Objective burden,
subjective burden
Intake, 6 months,
12 months
Economic
Evaluation
Assessment of Quality
of Life-6D45
Youth Quality
Adjusted Life
Years
Physical ability, social/
family relationships, mental
health, coping, pain, vision/
hearing/communication
Intake, 6 months,
12 months
Participant/Family
member Health
Services Use and
Out-of-Pocket Expense
Diary (Custom
questionnaire)
Youth, Family
member
Direct and
Indirect Costs
Health services usage,
participant/family member
out-of-pocket expenses,
lost time (employment and
leisure), third party payer
costs
Intake, 6 months,
12 months
Care provider
interactions with
participants (TAU and
ICCT versions)
TAU and ICCT
clinical staff
Direct and
Indirect Costs
Health services usage
participant/family member
out-of-pocket expenses,
lost time
Intake, 6 months,
12 months
Service
experiences
Continuity of Care in
Children’s Mental
Health44
Youth, Family
member
Continuity of
care
Experiences at this
agency, multiple providers
at agency, primary provider
at agency
Intake, 6 months,
12 months
Custom questionnaire Youth, Family
member
Goals None Intake, 6 months,
12 months
Satisfaction Ontario Perception of
Care Tool for Mental
Health and Addictions40
Youth, Family
member
Satisfaction Access to service, services
provided, participation/
rights, therapists/support
workers/staff, environment,
discharge, recovery
outcome, service quality
6 months,
12 months
Empowerment/
Engagement
Youth Efficacy/
Empowerment Scale43
Youth Empowerment Self, services, system Intake, 6 months,
12 months
Family Empowerment
Scale42
Family
member
Empowerment Family, child’s services,
involvement in community
Intake, 6 months,
12 months
DIAS-C,Diagnostic Interview for Affective and Anxiety Spectrum Disorders Child Version; GAIN SS, GAIN Short Screener; ICCT,Integrated
Collaborative Care Team; PCL-C,PTSD CheckList Civilian Version; PTSD, post-traumatic stress disorder; TAU,treatment as usual.
6 Henderson JL, et al. BMJ Open 2017;7:e014080. doi:10.1136/bmjopen-2016-014080
Open Access
Protected by copyright.
 o
n
 D
ecem
ber 18, 2019 at The Librarian J B M
orrell Library.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-014080 on 6 February 2017. Downloaded from 
healthcare system will be obtained through the Institute
for Clinical Evaluative Sciences (ICES), which holds
administrative healthcare use and cost data, such as
physician billings, hospital emergency services and
inpatient stays, for the province of Ontario. Since partici-
pants will not be prevented from engaging in concomi-
tant service use during the trial period, all service use
will be documented using the data collection tool.
Follow-up data will be collected from participants regard-
less of the amount of time during which they receive
services.
Randomisation
Sequence generation: Participants will be block-randomised
to the TAU or ICCT arms using random block sizes for
two treatments within each of the two strata deﬁned by
sex, separately at each of the four hospital sites (62–63
participants in each of the 8 strata, for sex and site).
Randomisation will be executed using computer algo-
rithms generated by REDCap research software.46
Allocation concealment: Participants will be randomised
to the two study arms at entry into the trial. The alloca-
tion sequence will be concealed from the clinical RAs
responsible for consenting, registering and assessing par-
ticipants until all intake assessments are complete and
the clinical RA accesses the website to obtain the ran-
domisation result.
Implementation: The allocation sequence will be gener-
ated centrally by REDCap system and accessed by the
clinical RA at the time of randomisation. Clinical RAs
will receive a training session on the randomisation
process prior to study launch. To randomise, the clinical
RA will enter the sex of the participant into the software
to obtain stratiﬁed randomisation within that hospital
site.
Blinding: Clinical RAs will be blind to treatment alloca-
tion at intake, as intake assessments will be conducted
prior to randomisation. Data analysts will be blind as to
the treatment arms.
Data collection procedures
Clinical data: Clinical data will be collected by clinical
RAs at the intake visit. The intake meeting will be
∼2½ hours in length based on pilot tests. The clinical
RA will have access to an on-call clinician at all times
during appointments to provide support for emergent
issues. The assessment process will be repeated at
6 months and 12 months. Data from assessments will be
directly collected into the electronic data capture system
REDCap46 using a tablet application and stored on a
secure server hosted at CAMH.
Economic evaluation: Data will be collected by clinical
RAs at baseline, 6-month and 12-month follow-up
points. Site measures will be collected at each treatment
site. Additional information on clinical contacts will be
collected by clinical RAs from patient ﬁles (number, dur-
ation, type of service provider). At the end of the
follow-up period, and once data is available, the health
card number will be used to link the patient to their
healthcare usage data from the Ministry of Health and
Long-Term Care (MOHLTC). This data will be accessed
through the Institute for Clinical Evaluative Sciences.
The data will remain de-identiﬁed throughout the ana-
lysis (healthcare visits, emergency department visits, hos-
pitalisations, specialist referrals, etc; see Statistical Plan
below).
Table 3 Summary of data collected for evaluation of the economic impact of the two intervention arms
System*
Direct costs
Youth/family†
Out-of-pocket Time Indirect costs‡
▸ Acute inpatient hospitalisations
▸ Psychiatric inpatient hospitalisations
▸ Same-day surgeries
▸ ED visits
▸ Other ambulatory care (chemo clinic visits,
dialysis clinic visits)
▸ Physician services
▸ Diagnostic/laboratory tests
▸ Outpatient prescription drugs covered under
the ODB programme
▸ Home care
▸ Complex continuing care
▸ Long-term care
▸ Inpatient rehabilitation
▸ Assistive devices (not available from
2010-onwards)
▸ OOP costs spent visiting
health professionals
▸ Outpatient prescription drugs
not covered under the ODB
programme
▸ Equipment
▸ Community services
▸ Household help
▸ Time costs spent
visiting health
professionals
▸ Time lost from
work and leisure
▸ Lost productivity
*Available through ICES.
†To be collected from youth and caregiver.
‡To be estimated and/or obtained from the literature.
ED, emergency department; ICES, Institute for Clinical Evaluative Sciences; ODB, Ontario Drug Benefit; OOP, out-of-pocket.
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Statistical plan
Analysis will be by intention to treat, and every attempt
will be made to collect outcome data from all partici-
pants, including those who do not complete treatment.
General linear models with repeated observations per
youth (6 and 12 months) will be used to compare treat-
ment and TAU groups with respect to outcome vari-
ables. Generalised estimation equations will be
employed for parameter estimation. The respective base-
line values will be added to the model as a covariate. For
the primary outcome, a two-sided level of 0.05 will be
used to examine for statistical signiﬁcance. To control
type I error probabilities, the analyses of secondary out-
comes and the subgroup analyses will employ a two-
sided level of 0.005. Subgroup analyses for the primary
and secondary outcomes will be performed based on
the following variables: age (14–16.5 vs 16.5–18 years
old), severity of functional impairment (CIS) at baseline,
disorder duration/age of onset and comorbidity of
mental health symptoms (DAIS-C and self-report mea-
sures), all dichotomised depending on the distribution.
Additional analyses will include examining, within treat-
ment arms, the between-site heterogeneity and identify-
ing baseline predictors of treatment response.
Participants will also be asked to report their impression
of the change observed, as an indication of clinical
signiﬁcance.47
Sample size determination and statistical power: A sample
size of 500 participants will provide 80% power for the
primary outcome, that is, the CIS.32 This is based on the
alternative hypothesis that the arms differ by 0.15 SD at
6 months and 0.3 SD at 12 months, α=0.05 (two-sided),
and an intraclass correlation coefﬁcient ≤0.4 between
the 6-month and 12-month observation periods. An
effect size of 0.3 SD is considered the smallest that is
clinically relevant and represents at most a 3-point differ-
ence on a scale of 0–52.
Economic evaluation: The economic evaluations will
take both a healthcare system and societal perspective;
these will include a CEA and a CUA. The time horizon
will be the youth’s lifetime. For the CEA, we will account
for direct costs to the healthcare system and to the
youth/family members, as well as indirect costs. Costs
will be adjusted for inﬂation to 2018 Canadian dollars
using the Statistics Canada Consumer Price Index for
health and personal care.48 All health outcomes and
costs will be discounted at 5%/year.49 We will account
for all costs associated with delivering the proposed
intervention. This will include costs with personnel, sup-
plies and services, equipment and programme resources,
among others. We will make use of a decision model in
our CEA to help incorporate the beneﬁts and costs
beyond the time horizon of the existing data, and to
help evaluate hypothetical scenarios. Health-related
costs for the standard care costing cohort will be deter-
mined through linkage to population-based administra-
tive databases at ICES using encrypted unique patient
identiﬁers.50 For each youth, we will determine the total
usage of health resources and respective costs during
the observation window in addition to the data collected
directly from participants.
The incremental cost-effectiveness ratio (ICER), the
primary outcome of the CEA, will be calculated as the
difference in discounted mean costs between the ICCT
and TAU groups divided by the difference in functional
impairment on the CIS. Similarly, for the CUA the ICER
will be a measure of the difference in costs divided by
the difference in QALYs between the treatment arms. A
95% CI around these estimates will be estimated non-
parametrically using 1000 bootstrap replications.
One-way deterministic sensitivity analyses will be per-
formed to evaluate the robustness of our results. The
ranges for the sensitivity analysis will be obtained from
95% CIs. We will also perform a probabilistic sensitivity
analysis using a second-order Monte Carlo simulation
with 1000 iterations. Using a net-beneﬁt framework,51 a
cost-effectiveness acceptability curve (CEAC) will be pro-
duced using varying willingness-to-pay thresholds. A
CEAC describes the probability that an intervention is
cost-effective, compared with the alternative, for a range
of maximum monetary values that a decision-maker may
be willing to pay for a particular unit change in the
outcome analysed. We will derive the CEAC from the
joint distribution of incremental costs and incremental
effects; we will use non-parametric bootstrapping of the
observed data to estimate these joint distributions.
For the CUA, we will measure the change in utility as
obtained from the AQOL-6D45 instrument, which will
allow us to calculate quality adjusted life years (QALYs).
The AQoL-6D is a validated, self-reported instrument
that contains 20 items that cover six domains of quality
of life, including ‘independent living’, ‘relationships’,
‘mental health’, ‘coping’, ‘pain’ and ‘senses’. The advan-
tage of the CUA approach is that QALYs capture general
well-being/disease burden directly from study partici-
pants. In addition, because the QALY is a widely used
measure in economic evaluations across all clinical disci-
plines, the results generated from this study will be easily
compared to the results of other, different healthcare
interventions.
As a subsequent analysis to the economic evaluation,
we also propose to examine the real world budget
impact of implementing ICCTs for hospitals that treat
adolescents across the province. One of the main objec-
tives of this analysis will be to determine how much the
Ontario Ministry of Health and Long-Term Care would
need to spend to implement this model of care either in
the entire province or in a given jurisdiction. Another
outcome of interest will be an estimate of the potential
savings achieved by the system by implementing this
intervention.
Confidentiality
The study will adhere to the Personal Health
Information Protection Act52 and all other regulatory
and organisational standards for privacy, conﬁdentiality
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and security of database information. All study investiga-
tors will sign conﬁdentiality agreements with ICES, fol-
lowing their guidelines, as PHI will be used to access
ICES data.
All identifying information will be stored in locked
cabinets separate from the study data. All study data will
be coded numerically and password protected in the
case of electronic data and stored on a secure server at
CAMH. Only study personnel will have access to this
data (including keys to cabinets for hard copies, knowl-
edge of passwords for data).
Records retention: Study data will be stored in compli-
ance with appropriate regulations.
Ethical considerations
This study will be conducted according to the guidelines
established by Good Clinical Practice (Food and Drug
Administration, http://www.fda.gov/oc/gcp/regulations.
html). Any protocol modiﬁcations will be communicated
to all relevant parties immediately as they are made.
Adverse events: Adverse events will be clearly documen-
ted at the central study site in an Adverse Event Log
immediately on notiﬁcation and duly reported to the
Research Ethics Board. An independent data safety
monitoring panel will track and consider any adverse
events to ensure participant safety.
Regulatory binder
A regulatory Standard Operating Procedures binder will
be kept in a secure location in the project coordinator’s
ofﬁce. A separate binder containing personal health
information will also be kept in a locked drawer within
the project coordinator’s ofﬁce.
DISCUSSION
Our model of an ICCT addresses the current deﬁcien-
cies of the youth mental health system without replacing
any existing services. Rather, ICCTs will be a
state-of-the-art interface between existing agencies to
improve practices and service access, co-created with the
agencies themselves, youth, family members and other
important stakeholders.25 These teams will build inter-
agency and cross-sectoral linkages to provide a seamless
pathway of care from the identiﬁcation of a mental
health concern through transitions to low-intensity and
high-intensity mental health interventions, depending
on the needs of the youth and family members.
This ICCT model is innovative, brings together
evidence-informed interventions and combines input
from all stakeholders. Our partnership with youth and
family members, community service providers, outreach
services and targeted intervention programmes offer key
outcomes at all levels. Coupled with our strong focus on
research and evaluation, our model is expected to be of
signiﬁcant interest to the global youth mental health
community as this will be the ﬁrst RCT of similar models
now in use in Australia, Ireland and the UK.53–57 At the
local community level, we expect to strengthen mental
health awareness, capacity in delivering low-intensity
interventions and the ability and willingness of mental
health professionals to support high-risk youth in the
community using collaborative care models.
Evidence-informed treatments are expected to be used
more frequently, delivered earlier in the course of a
problem, with anticipated shorter waits to service. We
may experience savings to the healthcare system if
equivalent clinical outcomes can be achieved with less
expensive services. At the individual level, youth and
their families are expected to be more engaged in the
services available for their MHA concerns in their com-
munity and more satisﬁed when they interact with such
services. Youth and family members are expected to feel
more empowered as they contribute to and receive ser-
vices. Results will be disseminated through community
and peer-reviewed academic channels, including publi-
cation in peer-reviewed journals, presentation at aca-
demic and service provider conferences and reports to
community partners. Authorship will be determined
based on standard protocols regarding the substantial
contributions to study design, data analysis and inter-
pretation and article preparation.
Limitations
This study has several limitations that should be kept in
mind. First, since this project is focused on evaluating
models and systems of care complete efﬁcacy and ﬁdelity
analyses will not be available for individual interventions
within these systems. In addition, given the intentionally
broad inclusion criteria, this pragmatic study will include
individuals with a wide range of mental/addiction
health challenges; although the sample size may allow
for analysing data of youth grouped into broad MHA
groups, it will not be possible to identify the differential
impact of the systems of care or speciﬁc service compo-
nents for individuals with speciﬁc mental health/addic-
tion challenges. With the follow-up period limited to
1 year, it will not be possible to assess long-term impacts
of each system of care. Given the relatively small sample
size it is possible that there might be important differ-
ences between the recruitment sites in participant
characteristics and or treatments provided. The inability
to assess the degree of collaboration and sustainability of
the interventions are additional limitations.
CONCLUSION
This Integrated Collaborative Care Team model is innova-
tive in many respects and holds substantial promise for
the MHA system. By involving youth, family members and
other stakeholders through all phases of the project, we
have developed a service pathway that will meet the wide
variety of needs with which youth with MHA challenges
present. The multitude of services available in the
pathway include evidence-informed community inter-
ventions, peer mentorship and phone/text-based crisis
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support as well as rapid access to psychiatric care and
primary care services. By providing integrated, highly col-
laborative care geared to need, goals and preferences,
situated in youth-friendly environments within the com-
munity, this model is expected to substantially improve
the mental health of this vulnerable population, making
Ontario a leader in innovative systems of care.
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